As expected, the reduced proliferation rate and decreased expression of MyoD1, myogenin, and MHC would lead to impeded myotube formation in CIS myotubes, which was manifested by the in vitro experimental observation of remarkably decreased myotube area. This evidence concerns the gene MYOD1 and in situ carcinoma.